Medicine Man Technologies (OTCMKTS:SHWZ) Earns “Buy” Rating from Benchmark

Medicine Man Technologies (OTCMKTS:SHWZ)‘s stock had its “buy” rating reiterated by Benchmark in a research note issued on Wednesday, Benzinga reports. They currently have a $2.50 price target on the stock.

Medicine Man Technologies Stock Performance

OTCMKTS SHWZ remained flat at $0.22 during trading on Wednesday. 2,160 shares of the company’s stock were exchanged, compared to its average volume of 79,386. Medicine Man Technologies has a one year low of $0.01 and a one year high of $1.55. The business’s fifty day moving average is $0.29 and its two-hundred day moving average is $0.65.

About Medicine Man Technologies

Medicine Man Technologies, Inc, doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products.